What Does Geneos Therapeutics Do?

Total employees12
HeadquartersPlymouth Meeting
FoundedN/A

Geneos Therapeutics is a clinical-stage biopharmaceutical company pioneering the development of personalized, neoantigen-targeted immunotherapies for cancer. Their proprietary GT-EPIC™ (Geneos Therapeutics – Elicit, Prime, Immune, Cell) platform is designed to identify and target unique tumor mutations (neoantigens) specific to each patient. By creating custom-designed DNA-based therapies, Geneos aims to stimulate a patient's immune system to recognize and attack their individual cancer. Their lead programs are focused on treating advanced hepatocellular carcinoma (HCC) and other challenging cancers, often in combination with checkpoint inhibitors.

Where Is Geneos Therapeutics's Headquarters?

HQ Function

The headquarters serves as the central hub for Geneos Therapeutics' research and development, clinical operations, corporate administration, and strategic planning.

Notable Features:

The facility likely includes modern laboratory spaces equipped for DNA plasmid development and immunological research, alongside corporate offices.

Work Culture:

The work culture at Geneos Therapeutics is expected to be highly collaborative, science-driven, and patient-focused, with an emphasis on innovation and translational research in oncology.

HQ Significance:

Its location in the Philadelphia biotech corridor provides access to a rich ecosystem of research institutions, talent, and potential collaborators, crucial for a clinical-stage company.

Values Reflected in HQ: The headquarters likely reflects Geneos's commitment to cutting-edge science, precision medicine, and the development of transformative cancer treatments.

Location:

While headquartered in the US, Geneos Therapeutics conducts clinical trials that may involve sites and patients internationally. Their collaborations and partnerships can also extend globally to advance their personalized cancer immunotherapy programs. Their primary operational presence is centered in the United States.

Street Address:

420 Plymouth Road, Suite 200

City:

Plymouth Meeting

State/Province:

PA

Country:

USA

Where Else Does Geneos Therapeutics Operate Around the World?

No additional office locations available.

Buying Intent Signals for Geneos Therapeutics

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading Geneos Therapeutics? Meet the Executive Team

As of April 2025, Geneos Therapeutics' leadership includes:

Vijay Reddy, MD, MBA - President and Chief Executive Officer
Niranjan Y. Sardesai, PhD - Founder, Chief Scientific Officer & Chief Technology Officer
Joann L. Birkett - Chief Operating Officer
Samar G. M. S. Habash, PharmD - Vice President, Clinical Operations
Betty Pryce - Vice President, Finance & Administration

Who's Investing in Geneos Therapeutics?

Geneos Therapeutics has been backed by several prominent investors over the years, including:

Santé Ventures
Korea Investment Partners (KIP)

What Leadership Changes Has Geneos Therapeutics Seen Recently?

Hire0
Exits0

Based on publicly available information, Geneos Therapeutics has maintained a stable executive team over the past 12 months with no major publicly announced hires or departures at the senior executive level. The company continues to be led by its established leadership.

What Technology (Tech Stack) Is Used byGeneos Therapeutics?

Discover the tools Geneos Therapeutics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Geneos Therapeutics Email Formats and Examples

Geneos Therapeutics likely uses standard corporate email formats. The most common formats typically involve combinations of first name, last name, and initials.

[first_initial][last]@geneostx.com

Format

jdoe@geneostx.com

Example

70%

Success rate

What's the Latest News About Geneos Therapeutics?

GlobeNewswireOctober 24, 2023

Geneos Therapeutics Doses First Patient in Phase 2 Clinical Trial of its Personalized Cancer Vaccine, GNOS-PV, in Combination with Merck’s KEYTRUDA® (pembrolizumab) for Patients with Advanced Hepatocellular Carcinoma

Geneos Therapeutics announced the dosing of the first patient in its Phase 2 clinical trial (GT-30) evaluating GNOS-PV, a personalized cancer vaccine, in combination with Merck’s anti-PD-1 therapy, KEYTRUDA® (pembrolizumab), for patients with unresectable or metastatic advanced hepatocellular carcinoma (HCC) who have not received prior systemic therapy....more

GlobeNewswireJune 5, 2023

Geneos Therapeutics Presents Positive Interim Data from Ongoing Phase 1b/2a Clinical Trial in Advanced Hepatocellular Carcinoma at the 2023 ASCO Annual Meeting

Geneos Therapeutics presented positive interim data from its ongoing Phase 1b/2a clinical trial (GT-20) of GNOS-PV02, a personalized cancer vaccine, in combination with pembrolizumab and DNA-encoded IL-12 (INO-9012) in patients with advanced hepatocellular carcinoma (HCC). The data highlighted robust neoantigen-specific T cell responses and encouraging clinical activity....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Geneos Therapeutics, are just a search away.